Peripheral neuropathy associated with subcutaneous or intravenous bortezomib in patients with newly diagnosed myeloma treated within the GMMG MM5 phase III trial.

Abstract:
No abstract specified

Citation: Haematologica. 2016 Dec;101(12):e485-e487. doi: 10.3324/haematol.2016.151266. Epub 2016 Aug 18.

Date Published: 20th Aug 2016

Registered Mode: by PubMed ID

Authors: M. Merz, H. Salwender, M. Haenel, E. K. Mai, U. Bertsch, C. Kunz, T. Hielscher, I. W. Blau, C. Scheid, D. Hose, A. Seckinger, A. Jauch, J. Hillengass, M. S. Raab, B. Schurich, M. Munder, P. Brossart, C. Gerecke, H. W. Lindemann, M. Zeis, K. Weisel, J. Duerig, H. Goldschmidt

help Submitter
Activity

Views: 140

Created: 5th Nov 2024 at 16:18

help Tags

This item has not yet been tagged.

help Attributions

None

Powered by
(v.1.15.2)
Copyright © 2008 - 2023 The University of Manchester and HITS gGmbH